首页> 外文期刊>Kidney International Reports >5-YEAR SURVIVAL RATE OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN END-STAGE RENAL DISEASE IN INDONESIA: CAN CAPD BE SOLUTION FOR ESRD IN LOW INCOME DEVELOPING COUNTRY?
【24h】

5-YEAR SURVIVAL RATE OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS IN END-STAGE RENAL DISEASE IN INDONESIA: CAN CAPD BE SOLUTION FOR ESRD IN LOW INCOME DEVELOPING COUNTRY?

机译:印度尼西亚末期肾病中连续动态腹膜透析的5年生存率:CAPD在低收入发展国的ESRD解决方案吗?

获取原文
获取外文期刊封面目录资料

摘要

Introduction: There are an increase in End-Stage Renal Disease (ESRD) patients in developing countries every year, including Indonesia. Based on the 2018 Indonesian Basic Health Research, 3.8&of the Indonesian population is ESRD patient. The number of available hemodialysis machines and hemodialysis nurses in Indonesia is far from optimal, and the number of procedures and success rate of kidney transplants is still very low. Considering those limitations, Continuous Ambulatory Peritoneal Dialysis (CAPD) therapy is chosen as an option for renal replacement therapy in Indonesia. This study is aimed to report the 5-year survival of ESRD patients undergoing CAPD therapy in low income developing countries such as Indonesia.
机译:介绍:每年发展中国家的末期肾病(ESRD)患者都有增加,包括印度尼西亚。 基于2018年印度尼西亚基本健康研究,3.8&印度尼西亚人口的患者是eSRD患者。 印度尼西亚的可用血液透析机和血液透析护士的数量远非最佳,肾移植的程序数量和成功率仍然很低。 考虑到那些限制,选择连续的动态腹膜透析(CAPD)治疗作为印度尼西亚肾脏替代疗法的选择。 本研究旨在报告在印度尼西亚等低收入发展中国家接受CAPAD治疗的ESRD患者的5年生存期。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号